What is a stock summary page? Click here for an overview.
Business Description
Globus Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US3795772082
Share Class Description:
GMED: Class ADescription
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.66 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 1.13 | |||||
| Interest Coverage | 43.91 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.74 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.5 | |||||
| 3-Year EBITDA Growth Rate | 10.4 | |||||
| 3-Year EPS without NRI Growth Rate | 23 | |||||
| 3-Year FCF Growth Rate | 11.6 | |||||
| 3-Year Book Growth Rate | 21 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.96 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.77 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.72 | |||||
| 9-Day RSI | 38.64 | |||||
| 14-Day RSI | 37.84 | |||||
| 3-1 Month Momentum % | -3.88 | |||||
| 6-1 Month Momentum % | 13.75 | |||||
| 12-1 Month Momentum % | 49.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.54 | |||||
| Quick Ratio | 1.77 | |||||
| Cash Ratio | 1.04 | |||||
| Days Inventory | 268.72 | |||||
| Days Sales Outstanding | 80.99 | |||||
| Days Payable | 21.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.6 | |||||
| Shareholder Yield % | 0.76 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.9 | |||||
| Operating Margin % | 8.72 | |||||
| Net Margin % | 4.09 | |||||
| FCF Margin % | 16.08 | |||||
| ROE % | 2.56 | |||||
| ROA % | 2.03 | |||||
| ROIC % | 4.37 | |||||
| 3-Year ROIIC % | 0.97 | |||||
| ROC (Joel Greenblatt) % | 13.52 | |||||
| ROCE % | 5.06 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 96.73 | |||||
| Forward PE Ratio | 21.05 | |||||
| PE Ratio without NRI | 26.93 | |||||
| Shiller PE Ratio | 48.19 | |||||
| Price-to-Owner-Earnings | 155.69 | |||||
| PEG Ratio | 2.3 | |||||
| PS Ratio | 3.96 | |||||
| PB Ratio | 2.39 | |||||
| Price-to-Tangible-Book | 5.11 | |||||
| Price-to-Free-Cash-Flow | 24.82 | |||||
| Price-to-Operating-Cash-Flow | 19.28 | |||||
| EV-to-EBIT | 44.51 | |||||
| EV-to-Forward-EBIT | 20.18 | |||||
| EV-to-EBITDA | 20.64 | |||||
| EV-to-Forward-EBITDA | 14.98 | |||||
| EV-to-Revenue | 3.88 | |||||
| EV-to-Forward-Revenue | 3.59 | |||||
| EV-to-FCF | 24.13 | |||||
| Price-to-GF-Value | 0.76 | |||||
| Price-to-Projected-FCF | 1.67 | |||||
| Price-to-DCF (Earnings Based) | 2 | |||||
| Price-to-DCF (FCF Based) | 1.41 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.1 | |||||
| Price-to-Graham-Number | 2.47 | |||||
| Price-to-Net-Current-Asset-Value | 9.03 | |||||
| Earnings Yield (Greenblatt) % | 2.25 | |||||
| FCF Yield % | 4.06 | |||||
| Forward Rate of Return (Yacktman) % | 15.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:GMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Globus Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,519.355 | ||
| EPS (TTM) ($) | 0.75 | ||
| Beta | 1.25 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.3 | ||
| Volatility % | 43.28 | ||
| 14-Day RSI | 37.84 | ||
| 14-Day ATR ($) | 2.176234 | ||
| 20-Day SMA ($) | 74.4325 | ||
| 12-1 Month Momentum % | 49.74 | ||
| 52-Week Range ($) | 49.33 - 94.93 | ||
| Shares Outstanding (Mil) | 137.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Globus Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Globus Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Globus Medical Inc Frequently Asked Questions
What is Globus Medical Inc(GMED)'s stock price today?
The current price of GMED is $72.55. The 52 week high of GMED is $94.93 and 52 week low is $49.33.
When is next earnings date of Globus Medical Inc(GMED)?
The next earnings date of Globus Medical Inc(GMED) is 2025-05-07 Est..
Does Globus Medical Inc(GMED) pay dividends? If so, how much?
Globus Medical Inc(GMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers